| Trial ID: | L0431 |
| Source ID: | NCT04321395
|
| Associated Drug: |
Vigabatrin
|
| Title: |
The Effect of Vigabatrin on Insulin Sensitivity
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD;Obesity
|
| Interventions: |
Drug: Vigabatrin;Drug: Placebo oral tablet
|
| Outcome Measures: |
Insulin SensitivityOral Glucose Tolerance
|
| Sponsor/Collaborators: |
Washington University School of Medicine
|
| Gender: |
All
|
| Age: |
18 Years60 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
20
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Triple (Participant, Care Provider, Investigator).
|
| Start Date: |
23/03/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 April 2021
|
| Locations: |
--
|
| URL: |
https://clinicaltrials.gov/show/NCT04321395
|
